118 studies found for:    "Pneumonia, Bacterial"
Show Display Options
Rank Status Study
1 Completed Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
2 Completed A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Ceftriaxone;   Drug: beta-lactam
3 Completed
Has Results
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-acquired
Interventions: Drug: Ceftaroline;   Drug: Levofloxacin
4 Terminated
Has Results
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-Acquired Infections;   Nosocomial Infection;   Pneumonia, Ventilator-Associated
Interventions: Drug: Cefepime placebo;   Drug: Cefepime;   Drug: Doripenem;   Drug: Doripenem placebo;   Drug: Amoxicillin/clavulanate potassium
5 Recruiting A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: ME1100 inhalation solution
6 Completed Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin fosfomycin inhalation solution;   Drug: Aerosolized placebo
7 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
8 Completed Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
9 Completed Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia
Interventions: Drug: Levofloxacin;   Drug: CEM-101
10 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions: Community-Acquired Bacterial Pneumonia;   Lung Infection of Individual Not Recently Hospitalized
Interventions: Drug: Ceftaroline;   Drug: Ceftriaxone
11 Recruiting CTTI Risk Factors for HABP/VABP Study
Conditions: Pneumonia, Ventilator-Associated;   Pneumonia, Bacterial;   Pneumonia, Hospital-Acquired
Intervention:
12 Recruiting Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Condition: Bacterial Pneumonia
Interventions: Drug: Imipenem;   Drug: Relebactam;   Drug: Cilastatin;   Drug: Piperacillin;   Drug: Tazobactam;   Drug: Linezolid
13 Withdrawn Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Intervention: Drug: Ceftaroline fosamil
14 Withdrawn Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Fosfomycin Inhalation Solution;   Drug: Aerosolized placebo
15 Completed A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Conditions: Pneumonia, Bacterial;   Nosocomial Infection;   Intraabdominal Infections;   Urinary Tract Infection
Intervention: Drug: No intervention
16 Unknown  Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
17 Completed Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
Condition: Pneumonia, Bacterial
Interventions: Other: 5 Days of Antibiotics;   Other: 7 Days of Antibiotics therapy for pneumonia
18 Recruiting Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Standard of Care
19 Completed Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin;   Other: Placebo to match solithromycin
20 Unknown  Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Conditions: Viral Pneumonia;   Bacterial Pneumonia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years